These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2878676)

  • 21. Comparative effects of xamoterol and digoxin in patients with mild to moderate heart failure. The Italian Xamoterol Multicenter Research Group.
    Eur Heart J; 1990 Apr; 11 Suppl A():50-1. PubMed ID: 1971591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy.
    Leslie PJ; Thompson C; Clarke BF; Ewing DJ
    Clin Auton Res; 1991 Jun; 1(2):119-23. PubMed ID: 1688039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure.
    Klein W; Eber B; Rotman B
    Angiology; 1992 Apr; 43(4):281-6. PubMed ID: 1348403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
    Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
    Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects and dose-response relationship of xamoterol in patients with ischaemic heart disease.
    Molajo AO; Bennett DH; Marlow HF; Snow HM; Bastain W
    Br J Clin Pharmacol; 1987 Sep; 24(3):373-9. PubMed ID: 2889460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
    Boström PA; Johansson BW; Lecerof H; Lilja B; Torp A
    J Intern Med; 1989 Nov; 226(5):331-5. PubMed ID: 2572666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xamoterol in sinus node disease.
    Avery PG; Small J; Shaw DB
    Int J Cardiol; 1993 Jun; 40(1):45-9. PubMed ID: 8349365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone.
    Paul V; Griffith M; Ward DE; Camm AJ
    Lancet; 1989 Aug; 2(8658):302-5. PubMed ID: 2569105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.
    Mehlsen J; Trap-Jensen J
    Acta Med Scand; 1986; 219(2):173-7. PubMed ID: 2870611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
    Marlow HF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
    Furlong R; Brogden RN
    Drugs; 1988 Oct; 36(4):455-74. PubMed ID: 2906865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of xamoterol in a patient with idiopathic autonomic failure.
    Elizabeth J; Solomon LR; Lye M
    J Auton Nerv Syst; 1992 Apr; 38(1):65-8. PubMed ID: 1350286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.
    Molajo AO; Coupe MO; Bennett DH
    Br Heart J; 1984 Oct; 52(4):392-5. PubMed ID: 6148092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
    Marlow HF
    Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is xamoterol safe in chronic airflow obstruction?
    Roberts JA; Challenor VF; Waller DG
    Eur J Clin Pharmacol; 1992; 42(2):147-50. PubMed ID: 1352245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of xamoterol in moderate cardiac insufficiency].
    Kayanakis JG; Larouchi L; Doat P; Grenet B; Fauvel JM; Bounhoure JP
    Presse Med; 1989 Apr; 18(13):667-70. PubMed ID: 2566161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
    Pouleur H; Hanet C; Rousseau MF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):82S-83S. PubMed ID: 2572263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate.
    Gilligan DM; Stewart R; Chan WL; Oakley CM
    Int J Cardiol; 1992 Jun; 35(3):377-86. PubMed ID: 1351887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.